Do analysts prefer PETV or HSCS?

HeartSciences has a consensus price target of $8.00, indicating a potential upside of 312.37%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is PETV or HSCS more profitable?

HeartSciences has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. HeartSciences' return on equity of -333.50% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% HeartSciences N/A -333.50% -140.18%

Do analysts rate HSCS or ZJYL?

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 312.37%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, HSCS or ZJYL?

Jin Medical International has higher revenue and earnings than HeartSciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HeartSciences N/A N/A -$8.77M -$4.94 N/A Jin Medical International $20.69M 0.93 $1.19M N/A N/A

Is HSCS or ZJYL more profitable?

Jin Medical International's return on equity of 0.00% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -333.50% -140.18% Jin Medical International N/A N/A N/A

Does the media prefer HSCS or ZJYL?

In the previous week, HeartSciences had 1 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for HeartSciences and 1 mentions for Jin Medical International. HeartSciences' average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jin Medical International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CODX or HSCS?

In the previous week, Co-Diagnostics and Co-Diagnostics both had 2 articles in the media. Co-Diagnostics' average media sentiment score of 0.00 equaled HeartSciences'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is FEMY or HSCS more profitable?

HeartSciences has a net margin of 0.00% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -521.97% -258.08% -73.72% HeartSciences N/A -333.50% -140.18%

Does the media favor FEMY or HSCS?

In the previous week, Femasys had 1 more articles in the media than HeartSciences. MarketBeat recorded 3 mentions for Femasys and 2 mentions for HeartSciences. HeartSciences' average media sentiment score of 0.00 beat Femasys' score of -0.03 indicating that HeartSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Femasys 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate MODD or HSCS?

HeartSciences has a consensus price target of $8.00, indicating a potential upside of 312.37%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation & earnings, MODD or HSCS?

HeartSciences is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Modular Medical N/A N/A -$18.82M -$14.71 N/A HeartSciences N/A N/A -$8.77M -$4.94 N/A

Is MODD or HSCS more profitable?

Modular Medical's return on equity of -245.85% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets Modular Medical N/A -245.85% -190.80% HeartSciences N/A -333.50% -140.18%

HeartSciences (HSCS) Competitors

$1.94 0.00 (0.00%)

Closing price 06/5/2026 03:59 PM Eastern

Extended Trading

$2.16 +0.22 (+11.29%)

As of 04:09 AM Eastern

Compare

HSCS vs. PETV, ZJYL, CODX, FEMY, and MODD

Should you buy HeartSciences stock or one of its competitors? MarketBeat compares HeartSciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HeartSciences include PetVivo (PETV), Jin Medical International (ZJYL), Co-Diagnostics (CODX), Femasys (FEMY), and Modular Medical (MODD). These companies are all part of the "medical equipment" industry.

How does HeartSciences compare to PetVivo?

PetVivo (NASDAQ:PETV) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

HeartSciences has lower revenue, but higher earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	25.42	-$10.95M	-$0.38	N/A
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A

In the previous week, HeartSciences had 2 more articles in the media than PetVivo. MarketBeat recorded 2 mentions for HeartSciences and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.00 equaled HeartSciences'average media sentiment score.

Company	Overall Sentiment
PetVivo	Neutral
HeartSciences	Neutral

HeartSciences has a consensus price target of $8.00, indicating a potential upside of 312.37%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

HeartSciences has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. HeartSciences' return on equity of -333.50% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
HeartSciences	N/A	-333.50%	-140.18%

PetVivo has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market. Comparatively, HeartSciences has a beta of 1.96, meaning that its share price is 96% more volatile than the broader market.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

HeartSciences beats PetVivo on 10 of the 14 factors compared between the two stocks.

How does HeartSciences compare to Jin Medical International?

HeartSciences (NASDAQ:HSCS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Jin Medical International's return on equity of 0.00% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-333.50%	-140.18%
Jin Medical International	N/A	N/A	N/A

HeartSciences currently has a consensus target price of $8.00, indicating a potential upside of 312.37%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has higher revenue and earnings than HeartSciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A
Jin Medical International	$20.69M	0.93	$1.19M	N/A	N/A

In the previous week, HeartSciences had 1 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for HeartSciences and 1 mentions for Jin Medical International. HeartSciences' average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jin Medical International	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

17.2% of HeartSciences shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

HeartSciences has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.23, suggesting that its stock price is 623% more volatile than the broader market.

Summary

HeartSciences beats Jin Medical International on 6 of the 11 factors compared between the two stocks.

How does HeartSciences compare to Co-Diagnostics?

Co-Diagnostics (NASDAQ:CODX) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

HeartSciences has a net margin of 0.00% compared to Co-Diagnostics' net margin of -6,760.63%. Co-Diagnostics' return on equity of -164.92% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Co-Diagnostics	-6,760.63%	-164.92%	-141.15%
HeartSciences	N/A	-333.50%	-140.18%

Co-Diagnostics currently has a consensus target price of $67.50, indicating a potential upside of 1,098.93%. HeartSciences has a consensus target price of $8.00, indicating a potential upside of 312.37%. Given Co-Diagnostics' higher probable upside, equities analysts clearly believe Co-Diagnostics is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Co-Diagnostics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Co-Diagnostics has a beta of 2.74, suggesting that its share price is 174% more volatile than the broader market. Comparatively, HeartSciences has a beta of 1.96, suggesting that its share price is 96% more volatile than the broader market.

In the previous week, Co-Diagnostics and Co-Diagnostics both had 2 articles in the media. Co-Diagnostics' average media sentiment score of 0.00 equaled HeartSciences'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Co-Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 5.4% of Co-Diagnostics shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

HeartSciences has lower revenue, but higher earnings than Co-Diagnostics. HeartSciences is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Co-Diagnostics	$718.17K	28.89	-$46.90M	-$15.77	N/A
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A

Summary

Co-Diagnostics beats HeartSciences on 6 of the 11 factors compared between the two stocks.

How does HeartSciences compare to Femasys?

Femasys (NASDAQ:FEMY) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Femasys has a beta of -2.23, suggesting that its stock price is 323% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market.

65.3% of Femasys shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 7.6% of Femasys shares are held by company insiders. Comparatively, 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HeartSciences has a net margin of 0.00% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
HeartSciences	N/A	-333.50%	-140.18%

HeartSciences has lower revenue, but higher earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	8.08	-$18.63M	-$0.27	N/A
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A

Femasys currently has a consensus price target of $5.33, indicating a potential upside of 1,640.64%. HeartSciences has a consensus price target of $8.00, indicating a potential upside of 312.37%. Given Femasys' stronger consensus rating and higher possible upside, research analysts plainly believe Femasys is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Femasys had 1 more articles in the media than HeartSciences. MarketBeat recorded 3 mentions for Femasys and 2 mentions for HeartSciences. HeartSciences' average media sentiment score of 0.00 beat Femasys' score of -0.03 indicating that HeartSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Femasys	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Femasys beats HeartSciences on 10 of the 15 factors compared between the two stocks.

How does HeartSciences compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

Modular Medical's return on equity of -245.85% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
HeartSciences	N/A	-333.50%	-140.18%

In the previous week, HeartSciences had 2 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for HeartSciences and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.00 equaled HeartSciences'average media sentiment score.

Company	Overall Sentiment
Modular Medical	Neutral
HeartSciences	Neutral

HeartSciences has a consensus price target of $8.00, indicating a potential upside of 312.37%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

HeartSciences is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
HeartSciences	N/A	N/A	-$8.77M	-$4.94	N/A

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Comparatively, 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Modular Medical has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.96, indicating that its stock price is 96% more volatile than the broader market.

Summary

HeartSciences beats Modular Medical on 8 of the 12 factors compared between the two stocks.

Get HeartSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSCS vs. The Competition

Export

Metric	HeartSciences	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.17M	$1.53B	$6.47B	$11.98B
Dividend Yield	N/A	N/A	2.67%	5.55%
P/E Ratio	-0.39	78.19	24.08	23.62
Price / Sales	N/A	6.78	516.49	109.93
Price / Cash	N/A	22.89	26.99	37.25
Price / Book	10.78	4.77	10.39	6.66
Net Income	-$8.77M	-$54.76M	$3.57B	$337.72M
7 Day Performance	-4.43%	-3.13%	-0.92%	-3.71%
1 Month Performance	0.52%	4.39%	3.55%	0.97%
1 Year Performance	-45.81%	-5.16%	23.80%	25.35%

HeartSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSCS HeartSciences	2.0709 of 5 stars	$1.94 flat	$8.00 +312.4%	-45.8%	$6.17M	N/A	N/A	10	Gap Up
PETV PetVivo	N/A	$0.72 -10.5%	N/A	-6.4%	$26.09M	$1.05M	N/A	20	Gap Up
ZJYL Jin Medical International	0.2792 of 5 stars	$3.21 -1.2%	N/A	-84.0%	$25.44M	$20.69M	N/A	245
CODX Co-Diagnostics	1.6949 of 5 stars	$5.17 -16.9%	$67.50 +1,205.6%	-37.5%	$22.92M	$620K	N/A	100
FEMY Femasys	1.8516 of 5 stars	$0.37 -0.9%	$5.33 +1,348.9%	-61.7%	$22.42M	$2.29M	N/A	30	Stock Split Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSCS) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HeartSciences (HSCS) Competitors

HSCS vs. PETV, ZJYL, CODX, FEMY, and MODD

How does HeartSciences compare to PetVivo?

Summary

How does HeartSciences compare to Jin Medical International?

Summary

How does HeartSciences compare to Co-Diagnostics?

Summary

How does HeartSciences compare to Femasys?

Summary

How does HeartSciences compare to Modular Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HeartSciences (HSCS) Competitors

HSCS vs. PETV, ZJYL, CODX, FEMY, and MODD

How does HeartSciences compare to PetVivo?

Which has higher earnings and valuation, PETV or HSCS?

Does the media refer more to PETV or HSCS?

Do analysts prefer PETV or HSCS?

Is PETV or HSCS more profitable?

Which has more risk and volatility, PETV or HSCS?

Do institutionals & insiders believe in PETV or HSCS?

Summary

How does HeartSciences compare to Jin Medical International?

Is HSCS or ZJYL more profitable?

Do analysts rate HSCS or ZJYL?

Which has higher earnings & valuation, HSCS or ZJYL?

Does the media prefer HSCS or ZJYL?

Do insiders & institutionals believe in HSCS or ZJYL?

Which has more risk & volatility, HSCS or ZJYL?

Summary

How does HeartSciences compare to Co-Diagnostics?

Is CODX or HSCS more profitable?

Do analysts rate CODX or HSCS?

Which has more risk & volatility, CODX or HSCS?

Does the media refer more to CODX or HSCS?

Do institutionals & insiders have more ownership in CODX or HSCS?

Which has better earnings & valuation, CODX or HSCS?

Summary

How does HeartSciences compare to Femasys?

Which has more risk & volatility, FEMY or HSCS?

Do institutionals & insiders believe in FEMY or HSCS?

Is FEMY or HSCS more profitable?

Which has better valuation & earnings, FEMY or HSCS?

Do analysts recommend FEMY or HSCS?

Does the media favor FEMY or HSCS?

Summary

How does HeartSciences compare to Modular Medical?

Is MODD or HSCS more profitable?

Does the media prefer MODD or HSCS?

Do analysts rate MODD or HSCS?

Which has better valuation & earnings, MODD or HSCS?

Do institutionals and insiders hold more shares of MODD or HSCS?

Which has more risk and volatility, MODD or HSCS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools